FDA gets 2 years to build patient recall alert system for implanted devices
H.R. 6594 — Medical Device Recall Improvement Act of 2025 · Filed by Jan Schakowsky (D-IL) · 1 cosponsor · Introduced Dec 10, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires medical device manufacturers to notify patients directly when their implanted or life-sustaining devices are recalled, using a standardized electronic format. The FDA must establish the notification system within 2 years, review manufacturer notifications within 2–3 business days, and maintain a public database of all device recalls. Manufacturers who fail to notify patients or use the required format face penalties under federal law.
Why we flagged it
The bill's core function is to establish mandatory electronic notification of device recalls directly to patients and healthcare providers, coupled with FDA oversight and public transparency. It is a regulatory procedural reform, not a substantive restriction on device approval or market access.
What the text implies
- The 180-day implementation window (after FDA establishes the format) may create a gap during which manufacturers continue using older, slower notification methods, delaying patient awareness of serious recalls.
- The bill does not specify penalties for late or incomplete notifications, only that refusal or failure is prohibited—enforcement discretion may vary by FDA administration.
The full analysis lists 5 implications of this text.
Who stands to gain
medical device manufacturers (modest compliance cost offset by reduced litigation risk from faster p; healthcare IT vendors (potential contracts to integrate electronic notification systems); patient advocacy organizations (increased transparency and data access)